Clinical Trials Logo

Clinical Trial Summary

Coronary heart disease (CHD) is one of the diseases characterised by biological aging as one of the important risk factors in several epidemiological studies. The mean telomere length and telomerase activity serve as markers for the biological age at the cellular level, with shorter telomeres and lower telomerase activity defining the increased biological age. Telomere length and telomerase activity, therefore, correlates with the risk of CHD and atherosclerosis. A present study states that the treatment with a statin is associated with a reduction in the number of clinical events but only in individuals with increased risk based on their telomere length. This suggests a positive relationship of telomere and telomerase system with the treatment with statins in CHD patients.


Clinical Trial Description

Coronary heart disease (CHD) is identified as one of the diseases characterised by biological aging as one of the important risk factors in several epidemiological studies. Premature biological aging is distinct from chronological aging and may predispose the individual to myocardial infarction, atherosclerosis and CHD in particular. The mean telomere length and telomerase activity serve as markers for the biological age at the cellular level, with shorter telomeres and lower telomerase activity defining the increased biological age. Telomere length and telomerase activity, therefore, correlates with the risk of CHD and atherosclerosis. Statins serve as the drugs of obvious choice based on their well established efficacy and safety profiles for the treatment of CHD and associated atherosclerosis. A present clinical study states that the treatment with a statin is associated with a reduction in the number of clinical events but only in individuals with increased risk based on their telomere length. This suggests a positive relationship of telomere and telomerase system with the risk of CHD and, therefore, would help clinicians to categorise the patient populations based on their leucocyte telomere length for treatment with statins. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02299245
Study type Interventional
Source Sun Yat-sen University
Contact
Status Active, not recruiting
Phase Phase 4
Start date October 2014
Completion date November 2016

See also
  Status Clinical Trial Phase
Recruiting NCT04638517 - The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis Phase 2
Completed NCT02844478 - Stress-Busting Program and QoL, Bio-markers of Immunity/Stress and Cellular Aging N/A
Completed NCT04763525 - Efficacy of Pythagorean Self-Awareness for Aging Biomarkers Improvement, in T2D Patients and Healthy Individuals. N/A
Not yet recruiting NCT03710356 - Evaluating Efficacy and Safety of Danazol in Severe Hematologic or Pulmonary Disease Related to Telomeropathy Phase 1/Phase 2
Recruiting NCT05508321 - Nasal Brushing for the Diagnosis and Understanding of Telomeropathies N/A
Completed NCT03982589 - Telomere Length in Relation to Acute Stress Response in Critical Care Patients
Not yet recruiting NCT05978921 - Physical Exercise in Patients With Schizophrenia N/A
Terminated NCT05715372 - Genetic Evaluation and Modification of Lifestyles to Improve Female Life Expectancy N/A
Active, not recruiting NCT03286699 - Lifestyle Change for Better Health N/A
Not yet recruiting NCT05598359 - TA-65 and Aging Associated Microvascular Dysfunction N/A
Recruiting NCT06056375 - Biological and Behavioral Outcomes of Community Nature Walks Phase 1
Completed NCT02055456 - Nandrolone Decanoate in the Treatment of Telomeropathies Phase 1/Phase 2
Recruiting NCT04211714 - Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure Phase 1
Completed NCT03459053 - CBART: The Reduction of Psychological and Physiological Stress in Women Undergoing IVF N/A